The immunopathogenesis of rheumatic immune adverse events from checkpoint inhibitors: prospects for targeted therapy.
Sign Up to like & getrecommendations! Published in 2020 at "Current Opinion in Rheumatology"
DOI: 10.1097/bor.0000000000000684
Abstract: PURPOSE OF REVIEW The introduction of checkpoint inhibitors as well as other allied advances in cancer immunology has made immunotherapy a pillar in the treatment of cancer. At the same time, these therapies have been… read more here.
Keywords: rheumatic immune; adverse events; immunopathogenesis rheumatic; checkpoint inhibitors ... See more keywords